|
1
|
Siegel R, DeSantis C, Virgo K, Stein K,
Mariotto A, Smith T, Cooper D, Gansler T, Lerr C, Fedewa S, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun BL, Chen L, Fu H, Guo L, Guo H and
Zhang N: Upregulation of RICTOR gene transcription by the
proinflammatory cytokines through NF-κB pathway contributes to the
metastasis of renal cell carcinoma. Tumour Biol. 37:4457–4466.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Finley DS, Pantuck AJ and Belldegrun AS:
Tumor biology and prognostic factors in renal cell carcinoma.
Oncologist. 16 Suppl 2:S4–S13. 2011. View Article : Google Scholar
|
|
4
|
Xiong J, Liu Y, Jiang L, Zeng Y and Tang
W: High expression of long non-coding RNA lncRNA-ATB is correlated
with metastases and promotes cell migration and invasion in renal
cell carcinoma. Jpn J Clin Oncol. 46:378–384. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Song J, Chen X, Bai J, Liu Q, Li H, Xie J,
Jing H and Zheng J: Discoidin domain receptor 1 (DDR1), a promising
biomarker, induces epithelial to mesenchymal transition in renal
cancer cells. Tumour Biol. 37:11509–11521. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lauffenburger D and Horwitz AF: Cell
migration: A physically integrated molecular process. Cell.
84:359–369. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee J: The epithelial-mesenchymal
transition: New insights in signaling, development and disease. J
Cell Biol. 172:973–981. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Q, Hou L, Ding G, Li Y, Wang J, Qian B,
Sun J and Wang Q: KDM6B induces epithelial-mesenchymal transition
and enhances clear cell renal cell carcinoma metastasis through the
activation of SLUG. Int J Clin Exp Pathol. 8:6334–6344.
2015.PubMed/NCBI
|
|
10
|
Wang Z, Inuzuka H, Fukushima H, Wan L, Gao
D, Shaik S, Sarkar FH and Wei W: Emerging roles of the FBW7 tumour
suppressor in stem cell differentiation. EMBO Res. 13:36–43. 2011.
View Article : Google Scholar
|
|
11
|
Welcker M and Clurman BE: FBW7 ubiquitin
ligase: A tumour suppressor at the crossroads of cell division,
growth and differentiation. Nat Rev Cancer. 8:83–93. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Z, Inuzuka H, Zhong J, Wan L,
Fukushima H, Sarkar FH and Wei W: Tumor suppressor functions of
FBW7 in cancer development and progression. FEBS Lett.
586:1409–1418. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koepp DM, Schaefer LK, Ye X, Keyomarsi K,
Chu C, Harper JW and Elledge SJ: Phosphorylation-dependent
ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase.
Science. 294:173–177. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei W, Jin J, Schlisio S, Harper JW and
Kaelin WG Jr: The v-Jun point mutation allows c-Jun to escape
GSK3-dependent recognition and destruction by the Fbw7 ubiquitin
ligase. Cancer Cell. 8:25–33. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Welcker M, Orian A, Jin J, Grim JE, Harper
JW, Eisenman RN and Clurman BE: The Fbw7 tumor suppressor regulates
glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein
degradation. Proc Natl Acad Sci USA. 101:pp. 9085–9090. 2004;
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mao JH, Kim IJ, Wu D, Climent J, Kang HC,
DelRosario R and Balmain A: FBXW7 targets mTOR for degradation and
cooperates with PTEN in tumor suppression. Science. 321:1499–1502.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gupta-Rossi N, Le Bail O, Gonen H, Brou C,
Logeat F, Six E, Ciechanover A and Israël A: Functional interaction
between SEL-10, an F-box protein, and the nuclear form of activated
Notch1 receptor. J Biol Chem. 276:34371–34378. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thompson BJ, Buonamici S, Sulis ML,
Palomero T, Vilimas T, Basso G, Ferrando A and Aifantis I: The
SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell
leukemia. J Exp Med. 204:1825–1835. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Akhoondi S, Sun D, von der Lehr N,
Apostolidou S, Klotz K, Maljukova A, Cepeda D, Fiegl H, Dafou D,
Marth C, et al: FBXW7/hCDC4 is a general tumor suppressor in human
cancer. Cancer Res. 67:9006–9012. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hubalek MM, Widschwendter A, Erdel M,
Gschwendtner A, Fiegl HM, Müller HM, Goebel G, Mueller-Holzner E,
Marth C, Spruck CH, et al: Cyclin E dysregulation and chromosomal
instability in endometrial cancer. Oncogene. 23:4187–4192. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee JW, Soung YH, Kim HJ, Park WS, Nam SW,
Kim SH, Lee JY, Yoo NJ and Lee SH: Mutational analysis of the hCDC4
gene in gastric carcinomas. Eur J Cancer. 42:2369–2373. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Guo Y, Liang X, Sun M, Wang G, De W
and Wu W: MicroRNA-223 functions as an oncogene in human gastric
cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol.
138:763–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng Y, Chen G, Martinka M, Ho V and Li
G: Prognostic significance of Fbw7 in human melanoma and its role
in cell migration. J Invest Dermatol. 133:1794–1802. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Santiago JM, Sasako M and Osorio J:
TNM-7th edition 2009 (UICC/AJCC) and Japanese Classification 2010
in Gastric Cancer. Towards simplicity and standardisation in the
management of gastric cancer. Cir Esp. 89:275–281. 2011.(In
Spanish).
|
|
25
|
Xu W, Wang Z, Zhang W, Qian K, Li H, Kong
D, Li Y and Tang Y: Mutated K-ras activates CDK8 to stimulate the
epithelial-to-mesenchymal transition in pancreatic cancer in part
via the Wnt/β-catenin signaling pathwa. Cancer Lett. 356:613–627.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fu Y, Lin Y, Yang Z, Yang G, Li G, Liu Y,
Tan X, Huang Y, Wu X, Wang Y, et al: FBXW7 overexpression
suppresses renal cancer cell proliferation and induces apoptosis.
Med Oncol. 32:2152015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Liu Y, Lu J, Zhang P, Wang Y, Xu
Y, Wang Z, Mao JH and Wei G: Rapamycin inhibits FBXW7 loss-induced
epithelial-mesenchymal transition and cancer stem cell-like
characteristics in colorectal cancer cells. Biochem Biophys Res
Commun. 434:352–356. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao J, Liu J, Xu R, Zhu X, Liu L and Zhao
X: MicroRNA-21 stimulates epithelial-to-mesenchymal transition and
tumorigenesis in clear cell renal cells. Mol Med Rep. 13:75–82.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song Y, Washington MK and Crawford HC:
Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal
transition in pancreatic cancer. Cancer Res. 70:2115–2125. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schmalhofer O, Brabletz S and Brabletz T:
E-cadherin, beta-catenin, and ZEB1 in malignant progression of
cancer. Cancer Metastasis Rev. 28:151–166. 2009. View Article : Google Scholar : PubMed/NCBI
|
